SÇSebahattin Çeli̇k

Sebahattin Çeli̇k

*This is an algorithmically generated author record based on publicly available information.

Sebahattin Çeli̇k has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of Folic Acid, B12, D, and E Vitamins and Melatonin levels in the follicular fluid taken by the Intracytoplasmic Sperm Injection method on pregnancy

    by KENAN DEMiR, Süleyman Tümer Çalişkan, Sebahattin Çeli̇k, Muhterem Akdeniz, Rümeysa Göç

    Objective: It has been demonstrated that the composition of the follicular fluid and many internal/external factors affect success in subfertile couples undergoing intracytoplasmic sperm injection (ICSI). We examined the effect of folic acid, B12, D, and E vitamins and melatonin values in follicular fluid on pregnancy in women with low, normal, and high ovarian reserves who underwent ICSI. Methods: Our study was conducted at Samsun Medical Park Hospital between January 2021 and February 2022. Follicular fluid induction samples were taken from 96 infertile women with low, normal, and high ovarian reserve, and ICSI was applied. Folic acid, B12, D, and E vitamins and melatonin levels were measured in follicular fluid samples by ELISA method. Statistical analyzes were done with SPSS, and ROC curve analyses were used. Results: Nine people with poor reserve, 19 people with normal reserve and 14 people with high reserve became pregnant. Folic acid, Vitamin-D, B12, E and melatonin levels were lower in those with poor ovarian reserve than in those with normal and high ovarian reserve (p<0.05). According to the pregnancy test, the probability of pregnancy was 43,783 times higher with high levels of folic acid, while it was 8,096 times higher for vitamin D. While vitamin B12 levels were 31,474 times more likely to be pregnancies, vitamin E levels were 35,227 times higher. For melatonin, the values showed that the probability of pregnancy increased by 11,564 times. Conclusions: High antioxidants may increase the likelihood of conception in infertile women undergoing ICSI. Therefore, couples who will be treated should be advised to increase these markers, especially melatonin in the follicular fluid. doi: https://doi.org/10.12669/pjms.40.3.7929 How to cite this: Demir K, Caliskan ST, Celik S, Akdeniz M, Goc RY. The effect of Folic Acid, B12, D, & E Vitamins and Melatonin levels in the follicular fluid taken by the Intracytoplasmic Sperm Injection method on pregnancy. Pak J Med Sci. 2024;40(3):433-437. doi: https://doi.org/10.12669/pjms.40.3.7929 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


  • Zonulin as a potential biomarker for diminished ovarian reserve: A prospective study

    by Sebahattin Çelik, Nazan Yurtcu, Canan Soyer Çalışkan, Samettin Çelik

    Objective: The purpose of this research is to investigate the relationship between zonulin levels and diminished ovarian reserve (DOR), and to evaluate the potential role of autoimmunity in the development of DOR. The study contributes to the understanding of the pathogenesis of DOR, which can be an unexpected diagnosis often associated with infertility and unpleasant physical symptoms in women. Materials and Methods: This cross-sectional study was conducted by scanning 224 patients. The demographic characteristics of the patients were recorded. Antral follicle counts of the patients were determined by ultrasound, and Anti-Mullerian hormone (AMH) levels were examined. Follicle-stimulating hormone (FSH), luteinizing hormone, estradiol, AMH measurement, and antral follicle counts were made on the 2nd or 3rd day of menstrual bleeding. The zonulin levels of the participants were measured by the ELISA method. The patients were divided into two groups according to the presence of DOR. The patients' demographic characteristics and hormone levels were compared between these two groups, serum zonulin levels were examined, and the relationship between other hormone parameters and zonulin was investigated. Results: When the median ages of the patients in both groups were compared, the median age of patients with DOR was 38 years, significantly higher (p<0.001) than the median age of those without DOR, which was 27 years. The median zonulin levels of both groups were compare; it was observed that it was 19.71 ng/mL in the group with DOR and 11.03 ng/mL without DOR, and a statistically significant difference was found between the zonulin levels of the patients in both groups (p<0.001). A moderate inverse correlation (p<0.001) between patients' zonulin and AMH levels, and a moderate correlation between FSH levels (p<0.001). Conclusion: In conclusion, zonulin levels of patients with DOR were higher than women without DOR. Evaluation of zonulin levels may also be considered during the diagnosis of DOR.


  • Open Access

    Evaluation of first- and third-trimester afamin levels in preeclampsia

    by Selim Gülücü, Sebahattin Çelik, Gökhan Unver

    The aim of this study was to investigate serum afamin levels in the first and third trimesters in preeclampsia. Serum samples from 118 patients in the first and third trimesters were analyzed. Serum samples were collected from pregnant women who had enrolled in the first trimester. Blood was then collected from pregnant women who had developed preeclampsia and from healthy controls in the third trimester. The collected blood samples were resolved for analysis, and serum afamin concentrations were measured in the first and third trimesters. Preeclampsia and healthy controls were compared. There was no significant difference between the control and preeclampsia groups in terms of age, body mass index, and smoking. Afamin levels in the first and third trimesters were higher in the preeclampsia group than in the control group (p<0.05). In the subgroup analysis of the preeclampsia group, afamin levels were higher in the early-onset preeclampsia group than in the late-onset preeclampsia group in the first and third trimesters (p<0.05). In the receiver operating characteristic analysis afamin levels were 96.23 ng/mL in the first trimester and 123.57 ng/mL in the third trimester as cut-off values for preeclampsia. Serum afamin levels are useful for predicting preeclampsia in the first trimester in pregnant women and can be used in clinical practice as a supportive biomarker for the diagnosis of preeclampsia in the third trimester. Meta-analyzes are needed to investigate the effect of afamin levels in the prediction and diagnosis of preeclampsia and to determine the cut-off value.


  • Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levels

    by Serkan Oral, Sebahattin Celik, Yasam Kemal Akpak, Hakan Golbasi, Burak Bayraktar, Gokhan Unver, Sami Sahin, Nazan Yurtcu, Canan Soyer Caliskan

    Purpose Zonulin has been shown to be associated with many metabolic disorders, including type 2 diabetes mellitus, metabolic syndrome, and obesity. In this study, we aimed to evaluate the association between maternal plasma zonulin levels and gestational diabetes mellitus (GDM) and its perinatal outcomes. Materials A total of 100 pregnant women, 56 with GDM and 44 controls, were included in this prospective case–control study. Maternal plasma zonulin levels were evaluated in each trimester. The association between zonulin levels and GDM, body mass index (BMI) and adverse perinatal outcomes was evaluated. The GDM predictability of zonulin levels for each trimester was analyzed with the receiver operator curve (ROC). Results Plasma zonulin levels were significantly higher in pregnant with GDM in all trimesters (p < 0.001; for all). Optimum cut-off values of plasma zonulin levels in predicting GDM: first trimester: 6.27 ng/mL, second trimester: 12.71 ng/mL, and third trimester: 18.38 ng/mL. BMI was significantly higher in pregnant women with GDM (30.5 vs 26.1; p < 0.001). Zonulin levels were significantly higher in pregnant women with GDM with overweight BMI [≥ 25–30 (kg/m2)] in all trimesters (p < 0.05; for all). Zonulin levels were significantly higher in pregnant women with composite adverse outcomes that included at least one of neonatal intensive care unit (NICU) admission, meconium-stained amniotic fluid, and 1st minute APGAR score < 7. Conclusion Increased maternal plasma zonulin levels were associated with increased risk of GDM and adverse perinatal outcomes. Zonulin may be a potential marker to predict GDM risk and perinatal outcomes.


  • Open Access

    İlk Trimester Serum Lipid Profili ile Postterm Gebelik İlişkisi

    by Selim Gülücü, Samettin Çeli̇k, Canan Soyer Çalişkan, Sebahattin Çeli̇k

    Amaç: Çalışmada ilk trimesterdeki lipid profili ile postterm gebelik (PTG) arasındaki ilişkiyi ve lipid profilinin PTG için bir öngörü kriteri olup olamayacağını değerlendirmeyi amaçladık.Materyal ve Metot: Çalışmaya postterm dönemdeki 329 (vaka grubu) ve term dönemdeki 97 (kontrol grubu) gebe dahil edildi. Hastaların demografik bilgileri, doğum şekilleri, ilk trimester lipid profilleri (total kolesterol, trigliserid, HDL-K, LDL-K, VLDL-K düzeyleri) ile doğan bebeklerin APGAR skoru ve yenidoğan yoğun bakım (YDYB) kabulu kaydedildi. Çalışmada gruplar arasındaki lipid profil farklılıkları değerlendirildi.Bulgular: Gruplar arasında yaş, gebelik sayısı, parite ve vücut kitle indeksi (VKI) açısından anlamlı farklılık saptanmazken, ortalama APGAR skorları (p<0,001) ve YDYB ihtiyacı (p<0,001) açısından anlamlı farklılık tespit edildi. PTG grubunda sezaryen (C/S) olma oranı term gruba göre daha yüksekti ve fark istatistiksel olarak anlamlı bulundu (p<0,001). Gruplar arasında lipid profilleri değerlendirildiğinde; total kolesterol, trigliserid, HDL-K, LDL-K ve VLDL-K düzeylerinin PTG grubunda anlamlı olarak daha düşük olduğu saptandı (p<0,05).Sonuç: Çalışmada, ilk trimester lipid düzeyi düşüklüğü ile PTG arasında anlamlı bir ilişki tespit edildi. Gebede ilk trimesterdeki düşük lipid seviyeleri, PTG’i öngörmek için bir kriter olarak değerlendirilebilir. Bununla beraber PTG’ye neden olabilecek başka faktörlerde bulunduğundan lipid profili ile PTG arasındaki ilişkinin daha iyi anlaşılabilmesi için destekleyici prospektif çalışmalara ihtiyaç vardır.

  • Role of Vitamin B12 and Vitamin D levels in intrahepatic cholestasis of pregnancy and correlation with total bile acid

    by Sebahattin Celik, Hakan Golbasi, Selim Gulucu, Mehmet Guclu, Canan Soyer Caliskan, Samettin Celik, Yasam Kemal Akpak, Ceren Golbasi

    This study aimed to evaluate the relationship between intrahepatic cholestasis of pregnancy (ICP) and Vitamin D and B12 levels. The study was a retrospective, cross-sectional, case–control study that evaluated 92 ICP cases and 102 pregnant women without any additional disease. ICP cases were grouped as mild and severe according to their total bile acid (TBA) levels, and their relationship with Vitamin D and B12 levels and perinatal outcomes was evaluated. Vitamin D and B12 levels of the ICP group were significantly lower than those of the control group. There was a moderate negative correlation between TBA and Vitamin D levels and a low negative correlation between TBA and Vitamin B12 levels. Adverse neonatal outcomes were significantly higher in the severe ICP group than in the mild ICP group.


  • Serum Lipid Profilinin Preeklampsi Öngörüsü ve Yenidoğan Sonuçları ile İlişkisi

    by Selim Gülücü, Mehmet Güçlü, Sebahattin Çeli̇k, İlkin Seda Can, Canan Soyer Çalişkan, Samettin Çeli̇k

    Amaç: İlk trimester lipid profilinin preeklampsi öngörüsünde faydasını ve yenidoğan sonuçlarıyla olan ilişkisini araştırmaktır. Gereç ve Yöntemler: Çalışmaya preeklampsi (PE) tanısı almış 121 hasta ve 99 sağlıklı gebe kadın dahil edildi. Çalışma retrospektif olarak dizayn edilmiştir. Hastaların yaş, gravida, parite, vücut kütle indeksi (VKI), doğum şekli, doğum kilosu, APGAR skoru, yenidoğan yoğun bakım ünitesi (YYBÜ) kabulü ve doğum haftası kaydedildi. Laboratuvar analizlerinde ilk trimester (


  • Predıctıve value of pregnancy of follıcular fluıd fetuın‐A and ‐B levels ın infertıle women after intra‐cytoplasmic sperm injection

    by Nazan Yurtcu, Serkan Oral, Sebahattin Celik, Suleyman Tumer Calıskan, Murat Alagoz, Michael H. Dahan

    Aim We aimed to investigate the value of follicular fluid fetuins-A and -B to predict successful IVF and pregnancy outcomes in infertile women with poor, normal, and high ovarian reserve. Methods The follicular fluid of 96 infertile women who underwent intra-cytoplasmic sperm injection (ICSI) procedure was analyzed. Fetuins-A and -B levels were examined and compared in those who could achieve pregnancy and those who could not. Receiver operating characteristic curve analyzes were used to determine cut-off and statistically significant associations for fetuins-A and -B. Results Follicular fluid fetuin-A levels were higher in cases with weak ovarian reserve (OR) (p < 0.05) and higher in patients who did not achieve clinical pregnancy (p < 0.05). Conversely, the follicular fluid fetuin-B levels were lower in cases with poor OR (p < 0.05) and were lower in patients who did not achieve a clinical pregnancy (p < 0.05). A follicular fluid fetuin-A concentration ≤ 19.12 ng/mL had a sensitivity and specificity of 94.74% and 93.1%, respectively, at predicting clinical pregnancy. While the follicular fluid fetuin-B concentration >24.7 ng/mL had sensitivity and specificity of 71.1% and 51.7%, respectively, for clinical pregnancy prediction. Conclusion Overall, high levels of follicular fluid fetuin-A may be independently associated with unsuccessful IVF irrespective of OR grouping. A low level of follicular fetuin-B was also associated with failed IVF. The sensitivity and specificity were found to be higher for fetuin-A in predicting clinical pregnancy. Therefore, the follicular fluid fetuin-A may be more predictive for successful IVF and clinical pregnancy outcomes than follicular fluid fetuin-B.


  • Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region

    by Nur Dokuzeylül Güngör, Samettin Çeli̇k, Mehmet Güçlü, Sebahattin Çeli̇k, Ferhat Cengi̇z

    Polycystic ovary syndrome (PCOS) is the most common endocrinopathy which is frequently associated with metabolic syndrome. The aim of this study is to compare the clinical, biochemical and hormonal characteristics of healthy women and women with PCOS in Black Sea Region. 91 healthy women (Group 1) and 109 PCOS (Group 2) patients were included in this retrospective study. This study was conducted in Samsun Women and Children’s Health Research and Training Hospital between October 2019-May 2020.The anthropometric, clinical and laboratory characteristics of the women were recorded. The Institutional Review Board of the hospital approved the study. IBM SPSS Statistics 22 program was used for statistical analysis. Variables were expressed as mean ± standard deviation or as a number (percentage), and statistical significance was defined as a p value of less than 0.05. In this study, no statistically significant difference was found between patients with PCOS and control subjects in age, height, BMI, waist circumference and waist-to-hip ratio. Weight, BP systolic, BP diastolic and FG scores, were significantly higher in patients with PCOS compared to control subjects. In this study, no statistically significant difference was found between patients with PCOS and control subjects in FSH, estradiol prolactin, TSH, fT3, fT4 and DHEASO4 levels. But, LH, cortisol, total and free testosterone and 17-OH progesteron levels were significantly higher in patients with PCOS compared to control subjects. Also in this study, vitamin B12 and the 25-OH-D levels were significantly lower in patients with PCOS compared to control subjects. HbA1C, fasting blood glucose levels, fasting insulin levels and HOMA-IR were significantly higher in patients with PCOS compared to control subjects . Total-C, LDL-C and TG levels were significantly higher in women with PCOS compared to control subjects. Also, HDL-C levels were significantly lower in women with PCOS compared to control subjects. As a result, the risk of metabolic syndrome is increased in PCOS patients because of high androgen levels, obesity and insulin resistance.